In clinical cohort studies, IL-6 presents as a crucial early mediator of inflammatory processes associated with major adverse cardiovascular events in CKD patients (Amdur et al., 2019; Batra et al., 2021). The gene discussed is IL6; the disease is chronic kidney disease.